Exchange: NASDAQ·Updated 07:30 PM EDT
CTSO logo

CTSO Cytosorbents Corp

$4.54
$0.14
(3.18%)
Today
Closed $4.54
$0.00
(0.00%)
After Hours
EarningsNov 12
Mkt Cap$14.31M
Vol24,112.00

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
44

Bearish Sentiment

How do you feel about CTSO?

SmartMoneyMike
SMART MONEY TRADES | $CTSO MONDAY TRADE PLAN 📈 $CTSO is on our radar with $4.11 as the key breakout level. BULLISH BREAKOUT: A clean break and hold above $4.11 with strong volume could set up a move toward $4.58, followed by $4.85 and potentially $5.25+ if momentum builds. PULLBACK OPPORTUNITIES: $3.75 — First area to watch for buyers stepping in. $3.50 — Secondary support if the pullback deepens. $3.25 — Deeper support level to monitor. WHAT WE WANT TO SEE: Volume confirming the breakout, buyers defending support, and higher lows forming before continuation. We’re not chasing green candles. We’re waiting for the setup to come to us. If you enjoy these trade plans throw us a ❤️
1
BiotechSwings
doubled in five sessions and still going $CTSO up 16 percent to 6.22 off a 5.35 close WBB upgraded it Wednesday, up 101 percent in five days imo
FlashAim
Join Starlight👇 A small-cap investing community focused on finding hidden value before the market does. Watchingg $CTSO $FVN as well
okeydokey_artichokey
$CTSO A biomed company could grab their entire portfolio of R&D, and products for a song.

Advertisement|Remove ads.